Filing Flows › Precision Biosciences (DTIL) › How it makes money
How Precision Biosciences (DTIL) makes money
Precision Biosciences (DTIL) made $10.8M of revenue in the third quarter fiscal 2026 (Q3 FY26), up 374-fold from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $10.8M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $10.8M | 374× |
| Q2 FY26 | $34.2M | 54× |
| Q1 FY26 | $13K | -98% |
| Q1 FY26 | $18K | -100% |
| Q3 FY25 | $29K | -100% |
| Q2 FY25 | $638K | -91% |
From Precision Biosciences' 10-Q filed May 5, 2026 (on EDGAR).
Questions
How does Precision Biosciences make money?
Precision Biosciences (DTIL) made $10.8M of revenue in the third quarter fiscal 2026 (Q3 FY26), up 374-fold from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.